Safety of rectal indomethacin(100 mg)for the prevention of post-ERCP pancreatitis in the Japanese population:A single-center prospective pilot study  

作　　者：Kotaro Takeshita Satoshi Asai Naoki Fujimoto Takumi Ichinona Eisuke Akamine Mamoru Takenaka 

机构地区：[1]Department of Gastroenterology,Tane General Hospital,Osaka 550-0025,Japan [2]Department of Gastroenterology and Hepatology,Kindai University Faculty of Medicine,Osaka-Sayama 589-8511,Japan

出　　处：《Hepatobiliary & Pancreatic Diseases International》2022年第4期406-408,共3页国际肝胆胰疾病杂志（英文版）

摘　　要：To the Editor:Endoscopic retrograde cholangiopancreatography(ERCP)causes adverse events;post-ERCP pancreatitis(PEP)is one of the frequent adverse events.Recently,the efficacy of rectal administration of non-steroidal anti-inflammatory drugs(NSAIDs)before or after ERCP for PEP prevention has been reported[1].

关 键 词：PREVENTION ERCP DRUGS 

分 类 号：R576[医药卫生—消化系统]